Globus Medical Inc logo

Globus Medical Inc - Class A

5
1
NYSE:GMED (USA)   Class A
$ 64.50 -0.03 (-0.05%) 02:03 PM EST
100.78
P/B:
2.22
Volume:
373.06K
Avg Vol (2M):
1.18M
Also Trade In:
Volume:
373.06K
Avg Vol (2M):
1.18M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Globus Medical Inc ( ) from 2012 to May 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Globus Medical stock (GMED) PE ratio as of May 16 2024 is 100.78. More Details

Globus Medical Inc (GMED) PE Ratio (TTM) Chart

To

Globus Medical Inc (GMED) PE Ratio (TTM) Historical Data

Total 1230
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Globus Medical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-16 100.8 2024-03-13 47.3
2024-05-15 100.8 2024-03-12 47.3
2024-05-14 98.2 2024-03-11 47.1
2024-05-13 99.6 2024-03-08 47.3
2024-05-10 101.1 2024-03-07 46.5
2024-05-09 100.6 2024-03-06 46.6
2024-05-08 96.5 2024-03-05 45.9
2024-05-07 80.3 2024-03-04 47.2
2024-05-06 78.5 2024-03-01 46.5
2024-05-03 81.2 2024-02-29 46.1
2024-05-02 78.9 2024-02-28 46.5
2024-05-01 78.8 2024-02-27 48.2
2024-04-30 77.8 2024-02-26 47.8
2024-04-29 79.1 2024-02-23 48.1
2024-04-26 79.0 2024-02-22 47.2
2024-04-25 78.7 2024-02-21 47.0
2024-04-24 80.4 2024-02-20 46.3
2024-04-23 80.1 2024-02-16 46.0
2024-04-22 80.1 2024-02-15 45.8
2024-04-19 78.7 2024-02-14 45.1
2024-04-18 79.3 2024-02-13 44.6
2024-04-17 80.0 2024-02-12 44.7
2024-04-16 80.9 2024-02-09 44.8
2024-04-15 81.0 2024-02-08 44.9
2024-04-12 80.7 2024-02-07 45.2
2024-04-11 82.0 2024-02-06 45.0
2024-04-10 83.0 2024-02-05 44.4
2024-04-09 83.9 2024-02-02 44.3
2024-04-08 83.1 2024-02-01 44.9
2024-04-05 81.0 2024-01-31 45.1
2024-04-04 80.0 2024-01-30 46.1
2024-04-03 81.8 2024-01-29 46.6
2024-04-02 81.0 2024-01-26 45.9
2024-04-01 83.0 2024-01-25 45.9
2024-03-28 83.8 2024-01-24 46.1
2024-03-27 45.4 2024-01-23 46.7
2024-03-26 44.1 2024-01-22 47.9
2024-03-25 43.7 2024-01-19 48.3
2024-03-22 44.5 2024-01-18 47.6
2024-03-21 44.6 2024-01-17 46.9
2024-03-20 44.3 2024-01-16 47.3
2024-03-19 44.4 2024-01-12 48.0
2024-03-18 44.1 2024-01-11 48.0
2024-03-15 43.9 2024-01-10 46.5
2024-03-14 44.3 2024-01-09 46.0

Globus Medical Inc (GMED) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Globus Medical Inc logo
Globus Medical Inc
NAICS : 339112 SIC : 3841
ISIN : US3795772082

Share Class Description:

GMED: Class A
Description
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.